Search research articles
Contact Us
Filters
Showing results (51-60 of 96) with videos related to
Page
of 10
Sort By:
British Journal of Cancer
|
March 29, 2000
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
G S Ogg, P R Dunbar, V Cerundolo, et al.
International Immunology
|
June 1, 1995
Isolation of a human allo-peptide presented by HLA-B51 molecules
H Tomiyama, Y Takamiya, A B Hill, et al.
FEBS Letters
|
July 14, 1999
Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway
K L Noakes, H T Teisserenc, J M Lord, et al.
Immunology Letters
|
June 1, 1997
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway
H Teisserenc, W Schmitt, N Blake, et al.
Human Immunology
|
October 31, 1998
Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells
N T Young, N A Rust, M J Dallman, et al.
The Journal of Experimental Medicine
|
March 17, 1999
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
D Valmori, U Gileadi, C Servis, et al.
Cancer Research
|
July 26, 2000
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12
R Mortarini, A Borri, G Tragni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 24, 2001
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6
M Evans, L K Borysiewicz, A S Evans, et al.
Cancer Research
|
February 10, 2000
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens
S J Youde, P R Dunbar, E M Evans, et al.
Ernst Schering Research Foundation Workshop
|
August 16, 2000
Immune monitoring in cancer immunotherapy
P Romero, M J Pittet, D Valmori, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 96) with videos related to
Sort By:
Page
of 10
British Journal of Cancer
|
March 29, 2000
Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexes
G S Ogg, P R Dunbar, V Cerundolo, et al.
International Immunology
|
June 1, 1995
Isolation of a human allo-peptide presented by HLA-B51 molecules
H Tomiyama, Y Takamiya, A B Hill, et al.
FEBS Letters
|
July 14, 1999
Exploiting retrograde transport of Shiga-like toxin 1 for the delivery of exogenous antigens into the MHC class I presentation pathway
K L Noakes, H T Teisserenc, J M Lord, et al.
Immunology Letters
|
June 1, 1997
A case of primary immunodeficiency due to a defect of the major histocompatibility gene complex class I processing and presentation pathway
H Teisserenc, W Schmitt, N Blake, et al.
Human Immunology
|
October 31, 1998
Independent contributions of HLA epitopes and killer inhibitory receptor expression to the functional alloreactive specificity of natural killer cells
N T Young, N A Rust, M J Dallman, et al.
The Journal of Experimental Medicine
|
March 17, 1999
Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3
D Valmori, U Gileadi, C Servis, et al.
Cancer Research
|
July 26, 2000
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12
R Mortarini, A Borri, G Tragni, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 24, 2001
Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6
M Evans, L K Borysiewicz, A S Evans, et al.
Cancer Research
|
February 10, 2000
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens
S J Youde, P R Dunbar, E M Evans, et al.
Ernst Schering Research Foundation Workshop
|
August 16, 2000
Immune monitoring in cancer immunotherapy
P Romero, M J Pittet, D Valmori, et al.
Page
of 10